Family History in the Context of CKD.

IF 9.4 1区 医学 Q1 UROLOGY & NEPHROLOGY Journal of The American Society of Nephrology Pub Date : 2025-03-11 DOI:10.1681/ASN.0000000653
Francesca Zanoni, Maddalena Marasa, Lucrezia Carlassara, Miguel Verbitsky, Atlas Khan, Chen Wang, Joshua D Bundy, Pietro A Canetta, Andrew S Bomback, Afshin Parsa, Harold I Feldman, Ali G Gharavi, Krzysztof Kiryluk
{"title":"Family History in the Context of CKD.","authors":"Francesca Zanoni, Maddalena Marasa, Lucrezia Carlassara, Miguel Verbitsky, Atlas Khan, Chen Wang, Joshua D Bundy, Pietro A Canetta, Andrew S Bomback, Afshin Parsa, Harold I Feldman, Ali G Gharavi, Krzysztof Kiryluk","doi":"10.1681/ASN.0000000653","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":" ","pages":"1561-1571"},"PeriodicalIF":9.4000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342073/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1681/ASN.0000000653","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性肾脏病的家族史。
背景:健康状况的家族史可能反映了共同的遗传和/或环境风险。目前尚不清楚家族史在多大程度上影响慢性肾病(CKD)患者的预后。在此,我们研究了CKD患者中CKD家族史、糖尿病以及其他常见合并症和肾脏疾病进展的相关性。方法:我们对两个前瞻性CKD队列进行了一项观察性研究,2573名成人和儿童来自治愈肾小球网络(CureGN)和3939名慢性肾功能不全队列(CRIC)成人参与者。自我报告的CKD、糖尿病和其他常见疾病的一级家族史使用多变量模型测试了与合并症和CKD进展风险的关联。结果:常见合并症的家族史与CKD中这些疾病的高风险相关,其中糖尿病约为3倍以上(调整OR为3.37,95% ci为2.73-4.15),癌症约为48%(调整OR为1.48,95% ci为1.05-2.09),心血管疾病约为69%(调整OR为1.69,95% ci为1.36-2.10)。虽然CKD的多基因风险评分与肾脏疾病进展相关(校正HR 1.11,合并队列中95% ci 1.06-1.16),但在已有CKD的情况下,肾脏疾病家族史并不是疾病进展的独立危险因素。相比之下,糖尿病家族史与独立于糖尿病发生的较高CKD进展风险或糖尿病多基因风险评分显著相关(校正HR 1.19,合并队列95% ci 1.05-1.35)。结论:在CKD背景下广泛收集家族史可以改善临床风险分层。在两个队列中,糖尿病家族史始终与较高的CKD进展风险相关,与糖尿病状态或糖尿病多基因风险评分无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of The American Society of Nephrology
Journal of The American Society of Nephrology 医学-泌尿学与肾脏学
CiteScore
22.40
自引率
2.90%
发文量
492
审稿时长
3-8 weeks
期刊介绍: The Journal of the American Society of Nephrology (JASN) stands as the preeminent kidney journal globally, offering an exceptional synthesis of cutting-edge basic research, clinical epidemiology, meta-analysis, and relevant editorial content. Representing a comprehensive resource, JASN encompasses clinical research, editorials distilling key findings, perspectives, and timely reviews. Editorials are skillfully crafted to elucidate the essential insights of the parent article, while JASN actively encourages the submission of Letters to the Editor discussing recently published articles. The reviews featured in JASN are consistently erudite and comprehensive, providing thorough coverage of respective fields. Since its inception in July 1990, JASN has been a monthly publication. JASN publishes original research reports and editorial content across a spectrum of basic and clinical science relevant to the broad discipline of nephrology. Topics covered include renal cell biology, developmental biology of the kidney, genetics of kidney disease, cell and transport physiology, hemodynamics and vascular regulation, mechanisms of blood pressure regulation, renal immunology, kidney pathology, pathophysiology of kidney diseases, nephrolithiasis, clinical nephrology (including dialysis and transplantation), and hypertension. Furthermore, articles addressing healthcare policy and care delivery issues relevant to nephrology are warmly welcomed.
期刊最新文献
Streamlining the Histopathological Workflow in Diabetic Kidney Disease with Artificial Intelligence. The Story of Aldosterone Escape. SGLT2 Inhibitors in ADPKD: Mechanistic Insights and Therapeutic Promise. Dissecting Normal and Abnormal Human Kidney Development Using Multi-omics. Redefining Immunosuppression in Older Kidney Transplant Recipients: Reflections on the OPTIMIZE Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1